EX-12.1 3 dex121.htm STATEMENT REGARDING COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES. Statement regarding computation of ratio of earnings to fixed charges.

Exhibit 12.1

 

RATIO OF EARNINGS TO FIXED CHARGES

 

ViroPharma Incorporated

Schedule of Ratio of Earnings to Fixed Charges

 

     Year

 
     1999

    2000

    2001

    2002

    2003

 

Net Loss from continuing operations

   (29,500,038 )   (41,817,374 )   (78,481,204 )   (26,622,883 )   (36,941,939 )

Add:

                              

Fixed charges

   404,756     10,062,007     11,938,260     11,393,160     8,838,401  
    

 

 

 

 

Earnings as adjusted

   (29,095,282 )   (31,755,367 )   (66,542,944 )   (15,229,723 )   (28,103,538 )
    

 

 

 

 

Fixed Charges:

                              

Interest (gross)

   153,956     9,102,914     10,800,693     10,248,483     7,825,657  

Portion of rent representative of the interest factor

   250,800     280,830     319,110     358,962     400,253  

Amortization of debt issuance costs

   —       678,263     818,457     785,715     612,491  
    

 

 

 

 

Total fixed charges

   404,756     10,062,007     11,938,260     11,393,160     8,838,401  
    

 

 

 

 

Deficiency of earnings to cover fixed charges

   29,500,038     41,817,374     78,481,204     26,622,883     36,941,939  
    

 

 

 

 

Rent expense

   760,000     851,000     967,000     1,087,763     1,212,889  
     33 %   33 %   33 %   33 %   33 %